Value of early blood Th-1 cytokine determination in predicting severity of acute pancreatitis

Scandinavian Journal of Gastroenterology

Volumn 33, Issue 5, 1998, Pages 554-560

  Heresbach, D ^a   Letourneur, J P ^b   Bahon, I ^b   Pagenault, M ^b   Guillou, Y M ^b   Dyard, F ^b   Fauchet, R ^b   Malledant Y ^b   Bretagne, J F ^b   Gosselin, M ^b  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

Acute pancreatitis severity; Cytokines; Septic complications

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR RECEPTOR;

ACUTE PANCREATITIS; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HUMAN; MALE; PREDICTION; PRIORITY JOURNAL; SEPSIS;

ACUTE DISEASE; ADULT; AGED; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKINS; MALE; MIDDLE AGED; PANCREATITIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, TUMOR NECROSIS FACTOR; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TH1 CELLS;

EID: 15444361470     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365529850172160     Document Type: Article

References (64)

1. Balthazar EJ, Ranson JHC, Naidich DP, Megibow AJ, Caccavale R, Cooper MM. Acute pancreatitis: prognostic value of CT1. Radiology;156:767-72.
2. Beger HG, Bittner R, Block S, Buchler M. Bacterial contamination of pancreatic necrosis: a prospective clinical study. Gastroenterology 1986;91:433-8.
3. Gerzof SG, Banks PA, Spechler SJ, Johnson WC, Snider JM, Wetzmer SM, et al. Role of guided percutaneous aspiration in early diagnosis on pancreatic sepsis. Dig Dis Sci 1984;29:50-5.
4. Ranson JHC, Balthazar E, Caccavale R, Cooper M. Computed tomography and the prediction of pancreatic abscess in acute pancreatitis. Ann Surg 1985;201:656-65.
5. Rotman N, Bonhet E, Larde D, Fagniez PL. Diagnosis value of computerized tomography in the complication of acute pancreatitis. Am J Surg 1986;152:286-9.
6. Sainio V, Kemppainen E, Puolakkainen P, Taavitsainen M, Kivisaari L, Valtonen V, et al. Early antibiotic treatment in acute necrotising pancreatitis. Lancet 1995;346:663-7.
7. Finch WT, Sawyers JL, Schenker S. A prospective study to determine the efficacy of antibiotics in acute pancreatitis. Am Surg 1976;113:667-71.
8. Yzet T, Delcenserie R. Prophylactic antibiotics in treatment of severe acute alcoholic pancreatitis. Pancreas 1996;13:198-201.
9. Pederzoli P, Bassi C, Vesentini S. A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg Gynecol Obstet 1993;176:480-3.
10. Gerzof SG, Banks PA, Robbins AH. Early diagnosis of pancreatic infection by computed tomography-guided aspiration. Gastroenterology 1987;93:1315-20.
11. Banks PA, Gerzof SG, Chong FK, Worthington MG, Doos WG, Sullivan JG, et al. Bacteriologic status of necrotic tissue in necrotizing pancreatitis. Pancreas 1990;5:330-3.
12. Hiatt JR, Fink AS, King W III. Percutaneous aspiration of peripancreatic fluid collections: a safe method to detect infection. Surgery 1987;101:523-30.
13. Karimgani I, Porter KA, Langevin RE, Banks PA. Prognostic factors in sterile pancreatic necrosis. Gastroenterology 1992; 103:1636-40.
14. Bittner R, Block S, Buchler M, Beger HG. Pancreatic abscess and infected pancreatic necrosis: different local septic complications in acute pancreatitis. Dig Dis Sci 1987;32:1082-7.
15. Fink AS, Hiatt JR, Pitt HA, Bennion RS, De Souza LR, McCoy RD, et al. Indolent presentation of pancreatic abscess. Experience with 100 cases. Arch Surg 1988;123:1067-72.
16. Lavigne L, Moreau J, Bertrand V, Escourrou J, Vaysse N, Frexinos J. Quelle fiabilité peut-on accorder aux critères biologiques dans l'évaluation précoce du pronostic d'une pancréatite aiguë? [abstract]. Gastroenterol Clin Biol 1994;18:A94.
17. Leser HG, Gross V, Scheibenbogen C, Heinisch A, Salm R, Lausen M, et al. Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology 1991;101:782-5.
18. Gross V, Scholmerich J, Leser HG, Salm R, Lausen M, Ruckauer K, et al. Granulocyte elastase in assessment of severity of acute pancreatitis. Comparison with acute-phase proteins C-reactive protein, alpha1-antitrypsin, and protease inhibitor alpha2-macroglobulin. Dig Dis Sci 1990;35:97-105.
19. Iovanna JL, Keim V, Nordback I, Montalto G, Camarena J, Letoublon C, et al. Serum levels of pancreatitis-associated protein as indicators ot the course of acute pancreatitis. Gastroenterology 1994;106:728-34.
20. Vesentini S, Bassi C, Talamini G, Cavallini G, Campedelli A, Pederzoli P. Prospective comparison of C-reactive protein level, Ranson score and contrastenhanced computed tomography in the prediction of septic complications of acute pancreatitis. Br J Surg 1993;80:755-7.
21. Curley PJ, McMahon MJ, Lancaster F, Banks RE, Barclay GR, Shefta J, et al. Reduction in circulating levels of CD4-positive lymphocytes in acute pancreatitis: relationship to endotoxin, interleukin 6 and disease severity. Br J Surg 1993; 80:1312-5.
22. Viedma JA, Pérez-Mateo M, Dominguez JE, Carballo F. Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A. Gut 1992;33:1264-7.
23. Viedma JA, Pérez-Mateo M, Agullo J, Dominguez JE, Carballo F. Inflammatory response in the early prediction of severity in human acute pancreatitis. Gut 1994;35:822-7.
24. Heath DI, Cruickshank A, Gudgeon M, Jehanli A, Shenkin A, Imrie CW. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993;34:41-5.
25. Pezzilli R, Billi P, Miniero R. Serum interleukin-6, interleukin-8, and β2-microglobulin in early assessment of severity of acute pancreatitis. Dig Dis Sci 1995;40:2341-8.
26. Bradley E. A clinically based classification system for acute pancreatitis. Arch Surg 1993;128:586-90.
27. Beck JR, Shultz EK. The use of relative operating characteristic (ROC) curves in test performance evaluation. Arch Pathol Lab Med 1986;110:13-20.
28. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. Apache II: a severity of disease classification system. Crit Care Med 1985; 13:818-29.
29. Le Gall JR, Loirat P, Alperovitch A. A simplified acute physiology score for ICU patients. Crit Care Med 1984;12:975-7.
30. Bouillot JL, Mariette D, Canel MA, Gaudez F, Baccot S, Boucherie JC, et al. Pronostic vital dans la pancréatite aiguë. Etude de 5 indices clinico-biologiques. Gastroenterol Clin Biol 1993;17:542-6.
31. Imrie CW, Benjamin IS, Ferguson JC. A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg 1978;65:337-41.
32. Blamey SL, Imrie CW, O'Neill J, Gilmour WH, Carter C. Prognostic factors in acute pancreatitis. Gut 1984;25:1340-6.
33. Tran DD, Cuesta MA. Evaluation of severity in patients with acute pancreatitis. Am J Gastroenterol 1992;87:604-611.
34. Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH. Acute pancreatitis: value of CT in establishing prognosis. Radiology 1990;174:331-6.
35. Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich P. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 1990;12:1179-86.
36. Sironi M, Breviario F, Proserpio Biondi A, Vecchi A, Van Damme J, et al. IL-1 stimulates IL-6 production in endothelial cells. J Immunol 1989;142:549-53.
37. Castell JV, Gomez-Lechon MJ, David M, Andus T, Geiger T, Trullenque R. Interleukin-6 is the major regulator of acute phase protein systhesis in adult human hepatocytes. FEBS Lett 1989;242:237-9.
38. Coulie PG, Cayphas S, Vink A, Uyttenhove C, Van Snick J. Interleukin1-related hybridoma and plasmacytoma growth factors induced by lipopolysaccharide in vivo. Eur J Immunol 1987;17:1217-20.
39. Tanakori I, Makoto H, Tomihiro H, Hirotaka O, Tamaki Y, Hisashi Y, et al. Interleukin-6 a useful marker for early prediction of severity of acute pancreatitis. Pancreas 1997;14:1-8.
40. Gross V, Andreesen R, Leser HG. Interleukin-8 and neutrophil activation in acute pancreatitis. Eur J Clin Invest 1992;22:200-3.
41. 2 microglobulin in early assement of severity of acute pancreatitis. Dig Dis Sci 1995;40:2341-8.
42. Tosato G, Jones KD. Interleukin-1 induces interleukin-6 production in peripheral blood monocytes. Blood 1990;75:1305-10.
43. Baggiolini M, Walz A, Kunkel S. Neutrophil-activating peptide 1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989;84:1045-9.
44. Seitz M, Dewald B, Gerber N, Baggiolini M. Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis. J Clin Invest 1991;87:463-9.
45. Eckmann L, Jung HC, Schürer-Maly C, Panja A, Morzycka-Wroblewska E, Kagnoff MF. Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin 8. Gastroenterology 1993;105:1689-97.
46. Norman JG, Fink GW, Franz MG. Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression. Arch Surg 1995;130:966-70.
47. Exley AR, Leese T, Holliday MP, Swann RA, Cohen J. Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis. Gut 1992;33:1126-8.
48. Tenner S, Sica G, Hughes M, Nordhoek E, Feng S, Zinner M, et al. Relationship of necrosis to organ failure in severe acute pancreatitis. Gastroenterology 1997;113:899-903.
49. Schindler BR, Mancilla J, Endres S, Ghorbani R, Clark SC, Dinarello CA. Correlations Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 1990;7:40-7.
50. Marshall JB. Acute pancreatitis. A review with an emphasis on new developments. Arch Intern Med 1993;153:1185-98.
51. Heinisch A, Meßmann H, Ballé C, Kadow R, Bloss U, Mann S, et al. TNF-receptor levels as prognostic parameter in acute pancreatitis [abstract]. Digestion 1995;56:292.
52. De Beaux AC, Goldie AS, Ross JA, Fearon KCH, Carter DC. Serum concentrations of tumor necrosis factor and its soluble receptors in patients with acute pancreatitis and their relationship to organ failure [abstract]. Digestion 1995;56:270.
53. Porteu F, Nathan C. Shedding of tumor necrosis factor receptors by activated human neutrophils. J Exp Med 1990;172:599-607.
54. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 1992;175:323-9.
55. VanZee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor in vitro and in vivo. Proc Natl Acad Sci USA 1992;89:4845-9.
56. Spinas GA, Keller U, Brockhaus M. Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia. J Clin Invest 1992;90:533-6.
57. Wallach D, Holtmann H, Aderka D, Rubinstein M, Avni YS, Sarov I, et al. Mechanisms which take part in regulation of the response to tumor necrosis factor. Lymphokine Res 1989;8:359.
58. Norman J, Messina J, Franz M, Riker A, Fabri PJ, Rosemurgy AS, et al. Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis [abstract]. Gastroenterology 1994;106:A311.
59. Arend WP. Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. J Clin Invest 1991;88:1445-51.
60. Dinarello CA. The proinflammatory cytokines and interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J Infect Dis 1991;163:1177-84.
61. McIntyre KW, Stephan GJ, Kolinsky KD, Benjamin WR, Plocinski JM, Koffka KL, et al. Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody. J Exp Med 1991;173:931-9.
62. Arend WP, Welgus HG, Thompson RC, Eisenberg SP. Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist. J Clin Invest 1990;85:1694-7.
63. Fischer E, VanZee KJ, Marano MA, Rock CS, Kenney JS, Poutsiaka DD, et al. Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood 1992;79:2196-200.
64. Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-73.